Blog

 

■ Subclinical hypothyroidism in children: Is it always subclinical?

1. Gallizzi, C. Crisafulli, T. Aversa, G. Salzano, F. De Luca, M. Valenzise, G. Zirilli

Ital J Pediatr. 2018; 44: 25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816505/

 

■ Mild hypothyroidism in childhood: Who, when, and how should be treated?

M C Vigone, D Capalbo, G Weber, M Salerno

J Endocr Soc 2018, vol 2 (9): 1024-1031

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117400/

 

■ A Klinefelter boy with congenital adrenal hyperplasia: Too much or too little androgens?

Giada Zanella, Gianluca Tornese, Elisabetta Mascheroni et al

Ital J Pediatr. 2018; 44: 43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883637/

 

■ Congenital hypopituitarism: How to select the patients for genetic analysis

Giuseppe Crisafulli, Tommaso Aversa, Giuseppina Zirilli et al

Ital J Pediatr. 2018; 44: 4

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889615/

 

■ Question and controversies about parathyroid pathophysiology in children with multiple endocrine neoplasia type 1

Stephen J. Marx, Delmar M. Lourenço, Jr.

Front Endocrinol (Lausanne) 2018; 9: 359

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057055/

 

■ Dislipidemia secundária em crianças obesas – Há evidência para tratamento farmacológico?

Radaelli, Graciane et al

Arq Bras Cardiol 2018, vol 111 (3): 356-361

http://www.scielo.br/pdf/abc/2018nahead/pt_0066-782X-abc-20180155.pdf

 

■ Does family history of obesity, cardiovascular, and metabolic diseases influence onset and severity of childhood obesity?

Domenico Corica, Tommaso Aversa, Mariella Valenzise et al

Front Endocrinol (Lausanne) 2018; 9: 18

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941161/

 

■ Hashimoto´s disease and thyroid cancer in children: Are they associated?

Laura Penta, Marta Cofini, Lucia Lanciotti, et al

Front Endocrinol (Lausanne) 2018; 9: 565

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189282/

 

■ Metabolic control in type 1 diabetes: Is adjunctive therapy the way forward?

Harriet Warnes, Rebecca Helliwell, Sam Matthew Pearson, Ramzi A. Ajjan

Diabetes Ther. 2018 Oct; 9(5): 1831–1851

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167310/

 

■ Cardiovascular autonomic neuropathy and glucose variability in patients with type 1 diabetes: Is there an association?

Szabolcs Nyiraty, Fruzsina Pesei, Andrea Orosz et al

Front Endocrinol (Lausanne) 2018; 9: 174

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916962/

 

■ Pharmacological treatment in diabetes mellitus type 1 – Insulin and what else?

E Otto-Buczkowska, N Jainta

Int J Endocrinol Metab 2018, vol 16 (1): e13008

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903388/

 

■ Metabolic control in type 1 diabetes: Is adjunctive therapy the way forward?

H Warnes, B Helliwell, S M Pearson, R A Ajja

Diabetes Ther 2018, vol 9 (5): 1831-1851

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167310/

 

■ Teens with type 1 diabetes: How does their nutrition measure up?

E R Mackey, L O´Brecht, C S Holmes et al

Journal of Diabetes Research 2018, Article ID 5094569, 9 pages

https://www.hindawi.com/journals/jdr/2018/5094569/

 

■ Type 1 diabetes mellitus: can coaching improve health outcomes?

Magalhães, Thais Pereira Costa et al

Arch Endocrinol Metab 2018, vol 62 (4): 485-448

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000400485&lng=en&nrm=iso

 

■ Fat and bone in children – Where are we now?

P Dimitri

Ann Pediatr Endocrinol Metab 2018, vol 23 (2): 62-69

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057021/

 

■ Exercício físico ou atividade física: Qual apresenta maior associação com a percepção da qualidade do sono de adolescentes?

Oliveira, Luciano Machado Ferreira Tenório de et al

Rev paul pediatr 2018, vol 36 (3): 322-328

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822018000300322&lng=pt&nrm=iso

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com

 

■ How are health-related behaviours influenced by a diagnosis of pré-diabetes? A meta-narrative review

Eleanor Barry, Trisha Greenhalgh, Nicholas Fahy

BMC Med. 2018; 16: 121

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062879/

 

■ Chikungunya and diabetes: What do we know?

Francisca Kalline de Almeida Barreto, Renan Magalhães Montenegro, Jr., Virginia Oliveira Fernande et al

Diabetol Metab Syndr. 2018; 10: 32.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899414/

 

■ Diabetes mellitus in HIV-infected patients: fasting glucose, A1C, or oral glucose tolerance test – Which method to choose for the diagnosis?

Ana Rita Coelho, Flávia Andreia Moreira, Ana Cristina Santos et al

BMC Infect Dis. 2018;  vol 18: 309

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035413/

 

■ Echocardiographic features of diabetic cardiomyopathy: Where are we now?

Kazuaki Negishi

Cardiovasc Diagn Ther. 2018, vol 8(1): 47–56

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835643/

 

■ Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: Does dose really matter?

Alexander Tenenbaum, Enrique Z. Fisman

Cardiovasc Diabetol. 2018; 17: 119

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112138/

 

■ Diabetes-related cognitive dysfunction: Hyperglycemia in the early stage might be a key?

Hiroyuki Umegaki

J Diabetes Investig. 2018 Sep; 9(5): 1019–1021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123037/

 

■ Cognitive function is impaired in patients with recently diagnosed type 2 diabetes, but not type 2 diabetes

Theresa van Gemert, Wolfgang Wölwer, Katharina S. Weber et al

GDS Group

J Diabetes Res. 2018; 2018: 1470476

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109580/

 

■ Metabolic control in type 1 diabetes: Is adjunctive therapy the way forward?

Harriet Warnes, Rebecca Helliwell, Sam Matthew Pearson, Ramzi A. Ajjan

Diabetes Ther. 2018 Oct; 9(5): 1831–1851

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167310/

 

■ Teens with type 1 diabetes: How does their nutrition measure up?

E R Mackey, L O´Brecht, C S Holmes et al

Journal of Diabetes Research 2018, Article ID 5094569, 9 pages

https://www.hindawi.com/journals/jdr/2018/5094569/

 

■ Type 1 diabetes mellitus: can coaching improve health outcomes?

Magalhães, Thais Pereira Costa et al.

Arch. Endocrinol. Metab., Aug 2018, vol.62, no.4, p.485-48

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000400485&lng=en&nrm=iso

 

■ Adenosine deaminase activity in type 2 diabetes mellitus: Does it have any role?

1. Niraula, S. Thapa, S. Kunwar, M. Lamsal, N. Baral, R. Maskey

BMC Endocr Disord. 2018; 18: 58

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102918/

 

■ Agonistas de GLP-1 inhibidores de SGL T2. Efectos cardioprotectores aditivos?

G J Matta-Herrera, L M Ballestas-Alarcón, A Ramírez-Rincón

Medicina Interna de México 2018, vol 4

http://www.medigraphic.com/pdfs/medintmex/mim-2018/mim184l.pdf

 

■ What information needs do people with recently diagnosed diabetes mellitus have and what are the associated factors? A cross-sectional study in Germany

S Grobosch, S Kuske, U Linnenkamp et al

BMJ Open 2018, vol 8 (10)

https://bmjopen.bmj.com/content/8/10/e017895

 

■ Serum adiponectin and insulin secretion: A direct or inverse association?

Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa et al

J Diabetes Investig. 2018 Sep; 9(5): 1106–1109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123038/

 

■ Exercise and glucagon-like-1: Does exercise potentiate the effect of treatment?

Hidetaka Hamasaki

World J Diabetes. 2018 Aug 15; 9(8): 138–140

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107470/

 

■ Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?

Peizhu Chen, Xuhong Hou, Gang Hu et al

Cardiovasc Diabetol. 2018;  vol 17: 93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020307/

 

■ Tiempo destinado a estar sentado y niveles de adiposidad ¿Cuál es su efecto sobre el desarrollo de diabetes mellitus tipo 2?.

Petermann, Fanny et al.

Rev. méd. Chile, Abr 2018, vol.146, no.4, p.433-441

https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000400433&lng=es&nrm=iso

 

■ Hidden risks behind normal fasting glucose: Is it significant?

Seung-Hwan Lee

Diabetes Metab J. 2018 Jun; 42(3): 196–197

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015962/

 

■ Combination of basal insulin and GLP-1 receptor agonist: Is this the end of basal insulin alone in the treatment of type 2 diabetes?

Rodrigo Oliveira Moreira, Roberta Cobas, Raquel C. Lopes Assis Coelh

Diabetol Metab Syndr. 2018; 10: 26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883417/

 

■ Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is ther a better basal insulin?

Chia‐Hsuin Chang, Lee‐Ming Chuang

J Diabetes Investig. 2018 Jul; 9(4): 728–730

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031505/

 

■ Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study

Angela Köninger, Annette Mathan, Pawel Mach et al

Reprod Biol Endocrinol. 2018; vol16: 30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870691/

 

■ Type 2 diabetes: When does it start?

Hiroyuki Sagesaka, Yuka Sato, Yuki Someya et al

J Endocr Soc. 2018 May 1; 2(5): 476–484

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932476/

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com